SlidesetHIVCharles Boucher, MD, PhD- HIV Macroprevention; epidemiology, phylogenic and networksView Slideset
SlidesetHIVThe impact of antiretroviral drugs on cardiovascular health- Jose Lopez-SendonView Slideset
SlidesetHIVThe impact of antiretroviral drugs on renal function- Bruce Hendry, BM, BCh, MD, PhDView Slideset
SlidesetHIVRisk of progression to osteoporosis in HIV-infected subjects and role of protease inhibitors- Dr. N. Perez - AlvaresView Slideset
SlidesetHIV15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy- Dr. A.M. TudorView Slideset
SlidesetHIVCase discussion: Co-morbidities in people living with HIV- Roger Paredes, MD, PhDView Slideset
SlidesetHIVCase discussion: How do drugs/patients impact need and type of monitoring- Laura Waters, MD, FRCPView Slideset
SlidesetHIVUnderdiagnosis and suboptimal care of diabetes mellitus in a French HIV-infected cohort in 2016 - Dr. A. SautereauView Slideset
SlidesetHIVCase discussion: How do drugs/patients impact need and type of monitoring- Marta Boffito, MD, PhD, FRCPView Slideset
SlidesetHIVThe rate of HIV transmission within serodiscordant heterosexual couples- Dr. A. TudorView Slideset
SlidesetHIVComprehensive and multidisciplinary assessment of HIV-infected population aged 60 years or older. Over60 cohort - Dr. E. NegredoView Slideset
SlidesetHIVValue-based healthcare in HIV management – The Economists Perspective- Phil McEwanView Slideset
SlidesetHIVValue-based healthcare in HIV management – The Clinicians’ Perspective- Jean-Jacques ParientiView Slideset
SlidesetHIVValue-based healthcare in HIV management – The Patienst’ Perspective - real life - Kees Brinkman, MD, PhDView Slideset
SlidesetHIVCase discussion: Demonstrative cases of social media based HIV and medical non-HIV programs in the community- Guido van den Berk, MD, PhDView Slideset